Author:
Odintsova G. V.,Nezdorovin O. V.,Nezdorovina V. G.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. B. Akarsu, D. Canbay Özdemir, D. Ayhan Baser, et al., “While studies on COVID-19 vaccine is ongoing, the public’s thoughts and attitudes to the future COVID-19 vaccine,” Int. J. Clin. Pract., 75, No. 4, e13891 (2021), https://doi.org/10.22541/au.159777189.93676219.
2. A. A. Asadi-Pooya, A. Emami, A. Akbari, and F. Javanmardi, “COVID-19 presentations and outcome in patients with epilepsy,” Acta Neurol. Scand. 143, No. 6, 624–628 (2021), https://doi.org/https://doi.org/10.1111/ane.13404.
3. V. V. Belopasov, Yashu Ya., E. M. Samoilova, and V. P. Baklaushev, “Nervous system damage in COVID-19 patients,” Klinich. Prakt., 11, No. 2, 60–80 (2020).
4. L. Coughlan, “Factors which contribute to the immunogenicity of non-replicating adenoviral vectored vaccines,” Front. Immunol., 11 (2020), https://doi.org/https://doi.org/10.3389/fimmu.2020.00909.
5. P. V. Karambelkar, C. S. Rojulpote, F. Saeed, et al., “The neurological manifestations of COVID-19 – A case series,” J. Clin. Transl. Res., 6, No. 4, 187–189 (2020), https://doi.org/https://doi.org/10.18053/jctres.06.202005.005.